A Histological Analysis of Burn Wound Progression

Total Page:16

File Type:pdf, Size:1020Kb

A Histological Analysis of Burn Wound Progression A HISTOLOGICAL ANALYSIS OF BURN WOUND PROGRESSION Raymond Thai Quan Bachelor of Biomedical Science Submitted in fulfilment of the requirements for the degree of Master of Philosophy School of Biomedical Sciences Faculty of Health Queensland University of Technology 2021 Keywords Anti-Fibrinogen, burn depth, burn marker, burn wound conversion, burn wound progression, damage marker, fibrin, formalin fixed; paraffin embedded, haematoxylin and eosin, histology, immunofluorescence, immunohistochemistry, MSB fibrin stain, pathology, porcine burn model, scald, skin, structural damage A Histological Analysis of Burn Wound Progression i Abstract Burn wound progression is the phenomenon in which burns progress in depth following the initial injury. This can cause superficial partial burns, which would normally heal within two weeks, to progress into deep-dermal partial thickness or full thickness burns, resulting in delayed healing and poorer long-term outcomes. In the literature, histological burn wound analysis involves the detection of multiple burn damage markers including collagen denaturation, cellular necrosis, cellular apoptosis, and vascular pathologies. A variety of histochemical and immunohistochemical stains have been utilised to detect these markers. In this study, Haematoxylin and eosin (H&E), Verhoeff’s Van Gieson (VVG), Gomori’s Trichrome (GT), Martius Scarlet Blue (MSB) and a fibrinogen antibody were optimised and evaluated for their ability to detect burn markers within a porcine scald burn model. H&E was effective for observing cellular necrosis, collagen denaturation and vascular pathologies. Collagen denaturation was also detected by VVG and GT with the additional detection of elastin fibres and vascular pathologies, respectively. MSB staining provided detection of collagen denaturation and vascular pathologies with the additional detection of fibrin deposition. Immunostaining for fibrinogen validated the fibrin staining in MSB. The analysis of burn wound progression was conducted by assessing a porcine burn wound model and comparing burns that progressed (n=6) within 72 hours to burns that did not progress (n=6). Sample replicates for each burn were obtained at one hour, 24 hours and 72 hours post-burn and comprised of high temperature, short duration and low temperature, long duration burns. A novel burn rubric for H&E stained tissue was developed to measure burn intensity, allowing for comprehensive analysis of the pathologies present in the entire section. Blood vessel occlusion was found to play a significant role in the progression of burns, with non-progression burns having higher intensity scores of completely occluded vessels at one hour post-burn. Increased intensity of partially occluded blood vessels was observed at 72 hours post- burn in burns that progressed. The difference in intensity of blood vessel damage between progression burns and non-progression burns demonstrates the complexity of assessing the mechanisms responsible for burn wound progression. A Histological Analysis of Burn Wound Progression ii The assessment of burns requires a multifaceted approach in determining the mechanisms involved in burn wound progression. This study developed a rubric to advance the current methods of burn assessment and found that vascular pathologies are a key marker in examining burn wounds and are of importance when assessing burn wound progression. A Histological Analysis of Burn Wound Progression iii Table of Contents Keywords .................................................................................................................................. i Abstract .................................................................................................................................... ii Table of Contents .................................................................................................................... iv List of Figures ......................................................................................................................... vi List of Tables .......................................................................................................................... xii List of Abbreviations ............................................................................................................. xiii Statement of Original Authorship ......................................................................................... xiv Acknowledgements ................................................................................................................ xv Chapter 1: Literature Review ............................................................................. 1 1.1 Burn Injuries .................................................................................................................. 1 1.2 Burn Wound Progression ............................................................................................... 2 1.3 Mechanisms of Burn Wound Progression and their measurement ................................ 3 1.3.1 Collagen Denaturation ............................................................................ 3 1.3.2 Cellular Necrosis .................................................................................... 5 1.3.3 Cellular Apoptosis .................................................................................. 6 1.3.4 Vascular Pathologies .............................................................................. 7 1.4 Burn Wound Model ..................................................................................................... 10 1.5 Summary and Gaps in Knowledge ............................................................................... 11 1.5.1 Summary .............................................................................................. 11 1.5.2 Gaps in Knowledge .............................................................................. 12 1.6 Thesis Outline .............................................................................................................. 13 1.7 Hypothesis and Aims ................................................................................................... 14 Chapter 2: Selection and Optimisation of Staining Methods......................... 15 2.1 Introduction .................................................................................................................. 15 2.2 Haematoxylin and Eosin .............................................................................................. 16 2.2.1 Introduction .......................................................................................... 16 2.2.2 Reagents ............................................................................................... 17 2.2.3 Initial Protocol ...................................................................................... 17 2.2.4 Optimisation ......................................................................................... 18 2.2.5 Evaluation in burned tissue .................................................................. 19 2.3 Verhoeff’s Van Gieson ................................................................................................ 21 2.3.1 Introduction .......................................................................................... 21 2.3.2 Reagents ............................................................................................... 21 2.3.3 Initial Protocol ...................................................................................... 21 2.3.4 Optimisation ......................................................................................... 22 A Histological Analysis of Burn Wound Progression iv 2.3.5 Evaluation in burned tissue .................................................................. 23 2.4 Gomori’s Trichrome .....................................................................................................25 2.4.1 Introduction .......................................................................................... 25 2.4.2 Reagents ............................................................................................... 26 2.4.3 Initial Protocol ...................................................................................... 26 2.4.4 Optimisation ......................................................................................... 26 2.4.5 Evaluation in burned tissue .................................................................. 29 2.5 Martius Scarlet Blue .....................................................................................................32 2.5.1 Introduction .......................................................................................... 32 2.5.2 Reagents ............................................................................................... 32 2.5.3 Protocol ................................................................................................ 32 2.5.4 Optimisation ......................................................................................... 33 2.5.5 Evaluation in burned tissue .................................................................. 35 2.6 Immunohistochemistry .................................................................................................37 2.6.1 Introduction .......................................................................................... 37 2.6.2 Reagents ............................................................................................... 37 2.6.3 Protocol
Recommended publications
  • Improved Postmortem Diagnosis of Taenia Saginata Cysticercosis
    IMPROVED POSTMORTEM DIAGNOSIS OF TAENIA SAGINATA CYSTICERCOSIS A Thesis Submitted to the College of Graduate Studies and Research in Partial Fulfilment of the Requirements for the Degree of Masters of Science in the Department of Veterinary Microbiology University of Saskatchewan Saskatoon By WILLIAM BRADLEY SCANDRETT Keywords: Taenia saginata, bovine cysticercosis, immunohistochemistry, histology, validation © Copyright William Bradley Scandrett, July, 2007. All rights reserved. PERMISSION TO USE In presenting this thesis in partial fulfilment of the requirements for a postgraduate degree from the University of Saskatchewan, I agree that the libraries of this university may make it freely available for inspection. I further agree that permission for copying of this thesis in any manner, in whole or in part, may be granted by the professor or professors who supervised my thesis work or, in their absence, by the Head of the Department or the Dean of the College in which my thesis work was done. It is understood that any copying or publication or use of this thesis or parts thereof for financial gain shall not be allowed without my written permission. It is also understood that due recognition be given to me and to the University of Saskatchewan in any scholarly use which may be made of any material in my thesis. Requests for permission to copy or to make use of material in this thesis in whole or in part should be addressed to: Head of the Department of Veterinary Microbiology University of Saskatchewan Saskatoon, Saskatchewan, S7N 5B4 i ABSTRACT Bovine cysticercosis is a zoonotic disease for which cattle are the intermediate hosts of the human tapeworm Taenia saginata.
    [Show full text]
  • Enophthalmos As the Initial Systemic Finding of Undiagnosed Metastatic Breast Carcinoma
    International Medical Case Reports Journal Dovepress open access to scientific and medical research Open Access Full Text Article CASE SERIES Enophthalmos as the Initial Systemic Finding of Undiagnosed Metastatic Breast Carcinoma This article was published in the following Dove Press journal: International Medical Case Reports Journal Jessica El-Khazen Dupuis Purpose: To report on the importance of detecting and investigating non-traumatic Michael Marchand enophthalmos, which occurred as the first presenting sign of an undiagnosed metastatic Simon Javidi breast carcinoma in two patients with no prior history of neoplasia. Tuan Quynh Tram Nguyen Design: Case series. Observations: The first case consists of a 74-year-old woman with no significant past Department of Ophthalmology, Centre medical history, who presented with a non-traumatic enophthalmos and ptosis of her left eye, Hospitalier de l’Université de Montréal (CHUM), Montreal, QC H2X 3E4, and horizontal diplopia on right-gaze. Imaging revealed an intraconal lesion of her left orbit, Canada with orbital fat atrophy. Transcutaneous anterior orbitotomy was performed for tumor biopsy, and the histopathology study concluded on a diagnosis of orbital metastasis consistent with infiltrative breast carcinoma. Thorough breast imaging and multiple breast biopsies were not able to localize the primary tumor. The second case consists of a 76-year-old woman, with no prior relevant medical history, who presented for progressive enophthalmos and ptosis of her right eye. Imaging revealed an osteolytic lesion of her right frontal bone, and multiple infiltrative lesions implicating both orbits. A biopsy was performed through a transcutaneous anterior orbitotomy and histopathology study lead to a diagnosis of meta­ static lobular breast carcinoma.
    [Show full text]
  • Prostate 1 Prostate
    Prostate 1 Prostate Prostate Male Anatomy Prostate with seminal vesicles and seminal ducts, viewed from in front and above. Latin prostata [1] Gray's subject #263 1251 Artery internal pudendal artery, inferior vesical artery, and middle rectal artery Vein prostatic venous plexus, pudendal plexus, vesicle plexus, internal iliac vein Nerve inferior hypogastric plexus Lymph external iliac lymph nodes, internal iliac lymph nodes, sacral lymph nodes Precursor Endodermic evaginations of the urethra [2] MeSH Prostate [3] Dorlands/Elsevier Prostate The prostate (from Greek προστάτης - prostates, literally "one who stands before", "protector", "guardian"[4] ) is a compound tubuloalveolar exocrine gland of the male reproductive system in most mammals unless they have it removed at birth.[5] [6] In 2002, female paraurethral glands, or Skene's glands, were officially renamed the female prostate by the Federative International Committee on Anatomical Terminology.[7] The prostate differs considerably among species anatomically, chemically, and physiologically. Prostate 2 Function The function of the prostate is to store and secrete a slightly alkaline fluid, milky or white in appearance,[8] that usually constitutes 20-30% of the volume of the semen along with spermatozoa and seminal vesicle fluid. The alkalinity of semen helps neutralize the acidity of the vaginal tract, prolonging the lifespan of sperm. The alkalinization of semen is primarily accomplished through secretion from the seminal vesicles.[9] The prostatic fluid is expelled in the first ejaculate fractions, together with most of the spermatozoa. In comparison with the few spermatozoa expelled together with mainly seminal vesicular fluid, those expelled in prostatic fluid have better motility, longer survival and better protection of the genetic material (DNA).
    [Show full text]
  • Treasures in Archived Histopathology Collections: Preserving the Past for Future Understanding
    Managing Editor, Nancy Klemme Scientific Editor, Vinnie Della Speranza, Vol. XLIII, No. 1 June 2010 MS, HTL(ASCP)HT, MT Treasures in Archived Histopathology Collections: Preserving the Past for (NOAA) National Marine Fisheries Service, and other agencies and Future Understanding academic institutions. The RTLA is a specimen depository and information Doranne Borsay Horowitz, BS, HT(ASCP)1; Esther C. Peters, PhD2; clearinghouse of cases submitted by Inke Sunila, PhD3; Jeffrey C. Wolf, DVM4 researchers from around the world, providing slides of neoplasms1,2 and [email protected] related diseases among reptiles, amphibians, fish, sharks, mollusks, 1US Environmental Protection Agency, Office of Research & Development, National Health & Environmental Effects Research Laboratory, Atlantic Ecology Division, Narragansett, RI arthropods, echinoderms, and coral. 2Department of Environmental Science and Policy, George Mason University, Fairfax, VA These archived collections are valuable 3 State of Connecticut, Department of Agriculture, Bureau of Aquaculture, Milford, CT resources for scientists seeking to 4Experimental Pathology Laboratories, Sterling, VA understand health and disease in diverse species (Fig. 1), for training new aquatic Abstract pathologists, predicting risks from biotic and abiotic stressors (eg, toxicant impacts Extensive collections of histopathology materials from studies of marine and on organisms in multiple locations), freshwater fish, mollusks, crustaceans, echinoderms, and other organisms are archived determining disease status through at the Registry of Tumors in Lower Animals (RTLA), the US Environmental DNA extraction and analysis, supplying Protection Agency (EPA), the National Oceanic and Atmospheric Administration data for historical reconstructions (eg, when a virus first affected a host species), A B IN THIS ISSUE Treasures in Archived Histopathology Collections: Preserving the Past for Future Understanding .
    [Show full text]
  • Ischemic Disease of the Intestine P.H
    7 Ischemic Disease of the Intestine P.H. MacDonald, D.J. Hurlbut and I.T. Beck 1. INTRODUCTION Intestinal ischemia occurs when the delivery of oxygen to the tissue is insuf- ficient to support its metabolic demand. Intestinal oxygen delivery can be impaired by both systemic and local vascular conditions. Atherosclerotic vas- cular disease is often implicated as a factor responsible for intestinal ischemia associated with altered systemic hemodynamics and accounts for the higher incidence of intestinal ischemia in the elderly population. Intestinal tissue blood flow and oxygen delivery may also be impaired as a result of locally mediated events within the intramural circulation of the gut. Such local events have been implicated in intestinal ischemia seen in both young and old patients. The true incidence of intestinal ischemia is unknown. Although overt cases are usually diagnosed correctly, it is generally believed that the condi- tion is often misdiagnosed in those presenting with non-specific abdominal pain. Indeed clinical manifestations of intestinal ischemia are varied and they depend on the site and method of vascular compromise as well as the extent of bowel wall necrosis. 2. CLASSIFICATION OF INTESTINAL ISCHEMIA Many clinicians broadly classify intestinal ischemia into acute or chronic dis- ease. However, because certain acute events may change to a chronic condition, a clear-cut classification of ischemic bowel disease using this two- category system is not always applicable. Since the extent of intestinal ischemia and the pathological consequences depend on the size and the location of the occluded or hypoperfused intestinal blood vessel(s), we find it useful to classi- fy ischemic bowel disease according to the size and type of the vessel(s) that are hypoperfused or occluded (Figure 1).
    [Show full text]
  • The C-Cells: Current Concepts on Normal Histology and Hyperplasia
    THE C-CELLS: CURRENT CONCEPTS ON NORMAL HISTOLOGY AND HYPERPLASIA ANGELA BORDA*, NICOLE BERGER**, M. TURCU***, M. AL JARADI**, SORANA VEREŞ**** *Histology Department, University of Medicine and Pharmacy, Târgu Mureş; **Pathology Department, Lyon Sud Hospital; ***Pathology Department, University of Medicine and Pharmacy, Târgu Mureş; ****”Petru Maior” University, Târgu Mureş Summary. We describe the current concepts on the embryology, normal morphology and immunohistochemistry of a minor cell population of the thyroid, the C-cells. We also try to make delineation between the normal number of the C-cells and C-cell hyperplasia. The two types of C-cell hyperplasia, physiologic and neoplastic are defined and characterized from morphologic and genetic point of view. Their relation with thyroid pathology, especially with medullary thyroid carcinoma is discussed. Key words: C-cell, C-cell hyperplasia, medullary thyroid carcinoma. INTRODUCTION Two distinct cell populations may be found in the thyroid parenchyma: the follicular cells, so far the most numerous, endodermally derived and synthesizing thyroglobulin, and the C-cells, a minor cell population, also known in the past as parafollicular cells, very different from the former in origin, morphologic appearance and function. The C-cells were first described in animals (rats and dogs). In the human thyroid, Pearse, using silver stain methods, recognized them only in 1966. He suggested that these cells contain calcitonin and coined their name: the C-cells. His finding was confirmed by the development of the immunohistochemistry and the anti-calcitonin antibody, demonstrating the presence of this hormone in the C-cells cytoplasm (Bussolati et al., 1967). By that time, it was also demonstrated that medullary carcinoma, a distinct form of thyroid carcinoma described by Hazard (1959), consisted of C-cells (Williams et al., 1989).
    [Show full text]
  • Histopathology of Prostate Tissue After Vascular-Targeted Photodynamic Therapy for Localized Prostate Cancer Caroline Eymerit-Mo
    Histopathology of prostate tissue after vascular-targeted photodynamic therapy for localized prostate cancer Caroline Eymerit-Morin, Merzouka Zidane, Souhil Lebdai, Stéphane Triau, Abdel Rahmene Azzouzi & Marie- Christine Rousselet Virchows Archiv The European Journal of Pathology ISSN 0945-6317 Volume 463 Number 4 Virchows Arch (2013) 463:547-552 DOI 10.1007/s00428-013-1454-9 1 23 Your article is protected by copyright and all rights are held exclusively by Springer- Verlag Berlin Heidelberg. This e-offprint is for personal use only and shall not be self- archived in electronic repositories. If you wish to self-archive your article, please use the accepted manuscript version for posting on your own website. You may further deposit the accepted manuscript version in any repository, provided it is only made publicly available 12 months after official publication or later and provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com”. 1 23 Author's personal copy Virchows Arch (2013) 463:547–552 DOI 10.1007/s00428-013-1454-9 ORIGINAL ARTICLE Histopathology of prostate tissue after vascular-targeted photodynamic therapy for localized prostate cancer Caroline Eymerit-Morin & Merzouka Zidane & Souhil Lebdai & Stéphane Triau & Abdel Rahmene Azzouzi & Marie-Christine Rousselet Received: 5 February 2013 /Revised: 23 April 2013 /Accepted: 8 July 2013 /Published online: 16 August 2013 # Springer-Verlag Berlin Heidelberg 2013 Abstract Low-risk prostate adenocarcinoma is classically Keywords Photodynamic therapy . Photosensitizer .
    [Show full text]